If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Genome Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Melanoma Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Genes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2024

Research Output 2000 2019

Revisiting the Clinical and Biologic Relevance of Partial PTEN Loss in Melanoma

Giles, K. M., Rosenbaum, B. E., Berger, M., Izsak, A., Li, Y., Illa Bochaca, I., Vega-Saenz de Miera, E., Wang, J., Darvishian, F., Zhong, H. & Osman, I., Feb 1 2019, In : Journal of Investigative Dermatology. 139, 2, p. 430-438 9 p.

Research output: Contribution to journalArticle

Melanoma
Tumors
Histone Deacetylase Inhibitors
Methylation
Epigenomics
1 Citation (Scopus)
Precision Medicine
Ovarian Neoplasms
RNA Sequence Analysis
Therapeutics
Neoplasms

Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions

Winterhoff, B. J., Kommoss, S., Heitz, F., Konecny, G. E., Dowdy, S. C., Mullany, S. A., Park-Simon, T. W., Baumann, K., Hilpert, F., Brucker, S., du Bois, A., Schröder, W., Burges, A., Shen, S., Wang, J., Tourani, R., Ma, S., Pfisterer, J. & Aliferis, MD, PhD, C., Jan 1 2018, In : AMIA ... Annual Symposium proceedings. AMIA Symposium. 2018, p. 1093-1102 10 p.

Research output: Contribution to journalArticle

Medical Informatics
Precision Medicine
Ovarian Neoplasms
Economics
Informatics
1 Citation (Scopus)

NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia

Tulstrup, M., Grosjean, M., Nielsen, S. N., Grell, K., Wolthers, B. O., Wegener, P. S., Jonsson, O. G., Lund, B., Harila-Saari, A., Abrahamsson, J., Vaitkeviciene, G., Pruunsild, K., Toft, N., Holm, M., Hulegårdh, E., Liestøl, S., Griskevicius, L., Punab, M., Wang, J., Carroll, W. L. & 5 othersZhang, Z., Dalgaard, M. D., Gupta, R., Nersting, J. & Schmiegelow, K., Dec 1 2018, In : Leukemia. 32, 12, p. 2527-2535 9 p.

Research output: Contribution to journalArticle

Thioguanine
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Nucleotides
Recurrence
Mutation
20 Citations (Scopus)

BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma

Paoluzzi, L., Hanniford, D., Sokolova, E., Osman, I., Darvishian, F., Wang, J., Bradner, J. E. & Hernando, E., Jun 1 2016, In : Cancer Medicine. 5, 6, p. 1183-1193 11 p.

Research output: Contribution to journalArticle

Melanoma
RNA Sequence Analysis
Neoplasms
Heterografts
Cell Line